Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen
- Association Between Use of SGLT2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes
- Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering
- Burden of Diseases, Injuries, and Risk Factors Among US States
- Effect of Hot Tea Consumption and Its Interactions With Alcohol and Tobacco Use on the Risk for Esophageal Cancer
- Serum n-6 Polyunsaturated Fatty Acids and Risk of Death
- Updated Guidelines on Syncope From the ESC
- Midlife Cardiovascular Fitness Associated With Decreased Risk of Dementia
- Major Adverse Limb Events in Lower Extremity Peripheral Artery Disease
- Exercise Therapy and Cardiovascular Toxicity in Cancer